Kairos Pharma, LTD. financial data

Symbol
KAPA on NYSE
Location
2355 Westwood Blvd. #139, Los Angeles, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.7M shares
Common Stock, Shares, Outstanding 13.7M shares +30%
Common Stock, Value, Issued 14K USD +27.3%
Weighted Average Number of Shares Outstanding, Basic 10.9M shares +5.57%
Weighted Average Number of Shares Outstanding, Diluted 10.9M shares +5.57%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 14K USD -57.6%
General and Administrative Expense 369K USD +45.3%
Operating Income (Loss) -383K USD -33.4%
Nonoperating Income (Expense) -664K USD -2556%
Net Income (Loss) Attributable to Parent -1.05M USD -236%
Earnings Per Share, Basic -0.1 USD/shares -233%
Earnings Per Share, Diluted -0.1 USD/shares -233%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 4.17M USD +4028%
Intangible Assets, Net (Excluding Goodwill) 222K USD -41.9%
Assets 5.77M USD +498%
Liabilities, Current 992K USD -58.8%
Liabilities 992K USD -67.4%
Retained Earnings (Accumulated Deficit) -8.82M USD -41.9%
Stockholders' Equity Attributable to Parent 4.78M USD
Liabilities and Equity 5.77M USD +498%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 13.7M shares +30%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.27M USD +1268%
Deferred Tax Assets, Valuation Allowance 841K USD -46.8%
Deferred Tax Assets, Gross 448K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.2M USD +39.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 13.6M USD +229%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%